| abstract |
Disclosed is an inhibitor of a cyclin-dependent kinase. In many embodiments thereof, the present invention prepares a novel class of pyrazolo [1,5-a] pyrimidine compounds as inhibitors of cyclin dependent kinases, one or more such compounds. Methods, pharmaceutical compositions containing one or more such compounds, methods for preparing pharmaceutical compositions containing one or more such compounds, and such compounds or pharmaceuticals Methods of treating, preventing, preventing or reducing one or more diseases associated with CDK using the compositions are provided. [Selection figure] None |